Abstract
Background and Aims: Diabetic foot ulcer is recognized as a consequence of peripheral neuropathy and peripheral arterial disease amid individuals with diabetes. As is well known, this situation still remains a crucial problem in nursing practice. Available studies describing an algorithm of inter- related nursing interventions concerned with diabetic foot ulcers are limited. Therefore, this integrative review was aimed to present evidence-based practice for overcoming the complications of diabetic foot ulcer as well as preventing lower extremity amputation.
Methods: This integrative review retrieved scientific literature from PubMed, CINAHL, ProQuest, SAGE Publishing and ScienceDirect databases as published from 2008 to 2017. Thirty-seven studies that met the inclusion criteria were included in this study.
Results: Our findings present that neurologic and circulatory assessments were considered as primary steps prior to conducting interventions. Formulating a diagnosis based upon the assessment results is a principal part to determine appropriate interventions. Multiple experimental studies displayed the effectiveness of certain interventions consist of applying wound cleansing, advanced modern wound dressing, topical therapy, offloading, intensive diabetes education and advanced treatment modalities. Hemoglobin A1c, high-density lipoprotein, procalcitonin, the potential of hydrogen of wound fluid, wound size, neurological and circulatory status were determined as the outcomes measurement which must be correctly evaluated.
Conclusion: This review contributes an algorithm for intervening diabetic foot ulcer thereby generating the given name: ADIE (Assessment, Diagnosis, Interventions, and Evaluation). A collaborative care amid multidisciplinary diabetes team is needed for implementing along with evaluating the feasibility of the study findings. Moreover, active family participation also plays a crucial role to achieve successful management of diabetic foot ulcer at home.
Keywords: Nursing care, diabetic foot, foot ulcer, review literature, amputations, diabetes complications, diabetic neuropathies.
[1]
Fernando ME, Crowther RG, Cunningham M, Lazzarini PA, Sangla KS, Golledge J. Lower limb biomechanical characteristics of patients with neuropathic diabetic foot ulcers: the diabetes foot ulcer study protocol. BMC Endocr Disord 2015; 15: 59.
[2]
Howarth D. Putting feet first: Preventing avoidable amputations. J Diabetes Nurs 2017; 21(7): 235.
[4]
Amin N, Doupis J. Diabetic foot disease: From the evaluation of the “foot at risk” to the novel diabetic ulcer treatment modalities. World J Diabetes 2016; 7(7): 153-64.
[6]
Tuttolomondo A, Maida C, Pinto A. Diabetic foot syndrome: Immune-inflammatory features as possible cardiovascular markers in diabetes. World J Orthop 2015; 6(1): 62-76.
[7]
Armstrong D, Wrobel J, Robbins J. Guest editorial: are diabetes-related wounds and amputations worse than cancer? Int Wound J 2007; 4: 286-7.
[9]
Parisi MCR, Neto MA, Menezes FH, et al. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetol Metab Syndr 2016; 8: 25.
[10]
Wang A, Xu Z, Ji L. Clinical characteristics and medical costs of diabetics with amputation at central urban hospitals in China. Zhonghua Yi Xue Za Zhi 2012; 92(4): 224-7.
[11]
Soewondo P, Ferrario A, Tahapary D. Challenges in Diabetes Management in Indonesia: A Literature Review. Global Health 2013; 9: 1-17.
[12]
Pemayun TGD, Naibaho RM, Novitasari D, Amin N, Minuljo TT. Risk factors for lower extremity amputation in patients with diabetic foot ulcers: A hospital based case-control study. Diabet Foot Ankle 2015; 6.
[14]
Fejfarová V, Jirkovská A, Dragomirecká E, et al. Does the diabetic foot have a significant impact on selected psychological or social characteristics of patients with diabetes mellitus? J Diabetes Res 2014; 2014371938
[15]
Widatalla AH, Mahadi SEI, Shawer MA, Elsayem HA, Ahmed ME. Implementation of diabetic foot ulcer classification system for research purposes to predict lower extremity amputation. Int J Diabetes Dev C 2009; 29(1): 1-5.
[16]
Delmas L. Best practice in the assessment and management of diabetic foot ulcers. Rehabil Nurs 2006; 31(6): 228-34.
[17]
Andrews KL, Houdek MT, Kiemele LJ. Wound management of chronic diabetic foot ulcers: From the basics to regenerative medicine. Prosthet Orthot Int 2015; 39(1): 29-39.
[18]
Holt P. Assessment and management of patients with diabetic foot ulcers. Nurs Stand 2013; 27(27): 49-55.
[19]
Turns M. Diabetic foot ulcer management: the podiatrist's perspective. Br J Community Nurs 2013; Suppl: S14: S16-9.
[20]
Krasner D, Sibbald R. Nursing management of chronic wounds: best practices across the continuum of care. Nurs Clin North Am 1999; 34(4): 933-53.
[21]
Marques A, Texeira A, Moreira T, Carvalho R, Fialho A, Chaves E. Nursing interventions for prevention of foot ulcers in patients with diabetes: an integrative review. Int Arch Med 2017; 10(163): 1-8.
[24]
Whittemore R, Knafl K. The integrative review: updated methodology. J Adv Nurs 2005; 52(5): 546-53.
[25]
Boisvert S, Proulx-Belhumeur A, Gonçalves N, Doré M, Francoeur J, Gallani MC. An integrative literature review on nursing interventions aimed at increasing self-care among heart failure patients. Rev Lat Am Nursing 2015; 23(4): 753-68.
[26]
Mantzoukas S. A review of evidence-based practice, nursing research and reflection: levelling the hierarchy. J Clin Nurs 2008; 17(2): 214-23.
[27]
Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4(1): 1.
[28]
American Diabetes Association. Standards of medical care in diabetes-2016. Diabetes Care 2016; (Suppl. 1)S1-S112.
[29]
Roberts P, Newton V. Assessment and management of diabetic foot ulcers. Br J Community Nurs 2011; 19(10): 485-6. 8-90
[30]
Lazarus G, Cooper D, Knighton D, et al. Definitions and guidelines for assessment of wounds and evaluation of healing. Arch Dermatol 1994; 130: 489-93.
[32]
Forsythe R, Hinchliffe R. Assessment of foot perfusion in patients with a diabetic foot ulcer. Diabetes Metab Res Rev 2016; 32(Suppl. 1): 232-8.
[33]
Young D, Flyinn K, Moss D, Schuerman S, Hartig K, Altenburger B. Reliability and Responsiveness of an 18 site, 10 g monofilament examination for assessment of protective foot sensation. J Geriatr Phys Ther 2011; 34: 95-8.
[34]
Richard J-L, Reilhes L, Buvry S, Goletto M, Faillie J-L. Screening patients at risk for diabetic foot ulceration: a comparison between measurement of vibration perception threshold and 10-g monofilament test. Int Wound J 2012; 11: 147-51.
[35]
Baraz S, Zarea K, Shahbazian HB, Latifi SM. Comparison of the accuracy of monofilament testing at various points of feet in peripheral diabetic neuropathy screening. J Diabetes Metab Syndr 2014; 13(1): 1-7.
[37]
Armstrong DG, Holtz-Neiderer K, Wendel C, Mohler MJ, Kimbriel HR, Lavery LA. Skin Temperature Monitoring Reduces the Risk for Diabetic Foot Ulceration in High-risk Patients. Am J Med 2007; 120(12): 1042-6.
[38]
Skafjeld A, Iversen MM, Holme I, Ribu L, Hvaal K, Kilhovd BK. A pilot study testing the feasibility of skin temperature monitoring to reduce recurrent foot ulcers in patients with diabetes – a randomized controlled trial. BMC Endocr Disord 2015; 15(1): 1-7.
[39]
Álvaro-Afonso FJ, Lázaro-Martínez JL, Aragón-Sánchez J, García-Morales E, García-Álvarez Y, Molines-Barroso RJ. What is the clinical utility of the ankle-brachial index in patients with diabetic foot ulcers and radiographic arterial calcification? IJLEW 2015; 14(4): 372-6.
[40]
American Diabtes Association. Peripheral arterial disease in people with diabetes. Diabetes Care 2003; 26(1): 3333-41.
[41]
Brownrigg JRW, Hinchliffe RJ, Apelqvist J, et al. Performance of prognostic markers in the prediction of wound healing or amputation among patients with foot ulcers in diabetes: a systematic review. Diabetes Metab Res Rev 2016; 32: 128-35.
[42]
Rac-Albu M, Iluita L, Guberna S, Sinescud C. The role of ankle-brachial index for predicting peripheral arterial disease. Maedica (Buchar) 2014; 9(3): 295-302.
[43]
Rayman G, Vas PR, Baker N, et al. The Ipswich Touch Test: A simple and novel method to identify inpatients with diabetes at risk of foot ulceration. Diabetes Care 2011; 34(7): 1517-8.
[44]
Sharma S, Kerry C, Atkins H, Rayman G. The Ipswich Touch Test: a simple and novel method to screen patients with diabetes at home for increased risk of foot ulceration. Diabet Med 2014; 31(9): 1100-3.
[45]
Madanat A, Sheshah E, Badawy E, Abbas A, Al-Bakheet A. Utilizing the Ipswich Touch Test to simplify screening methods for identifying the risk of foot ulceration among diabetics: The Saudi experience. Prim Care Diabetes 2015; 9(4): 304-6.
[46]
Woodbury MG, Sibbald RG, Ostrow B, Persaud R, Lowe JM. Tool for rapid & easy identification of high risk diabetic foot: Validation & clinical pilot of the simplified 60 second diabetic foot screening tool. PLoS One 2015; 10(6) e0125578
[47]
Greatrex-White S, Moxey H. Wound assessment tools and nurses’ needs: an evaluation study. Int Wound J 2013; 12(3): 293-301.
[48]
Bowering CK. Diabetic foot ulcers. Pathophysiology, assessment, and therapy. CFP 2001; 47: 1007-16.
[49]
Fard A, Esmaelzadeh M, Larijani B. Assessment and treatment of diabetic foot ulcer. Int J Clin Pract 2007; 61(11): 1931-8.
[51]
Frich L. Nursing interventions for patients with chronic conditions. J Adv Nurs 2003; 44(2): 137-53.
[52]
Schumann H, Calow T, Weckesser S, Muller M, Hoffmann G. Water-filtered infrared A for the treatment of chronic venous stasis ulcers of the lower legs at home: a randomized controlled blinded study. Br J Dermatol 2011; 165: 541-51.
[53]
Fernandez R, Griffiths R. Water for wound cleansing. Cochrane Database Syst Rev 2012; 15(2) CD003861
[54]
Bellingeri A, Falciani F, Traspedini P, et al. Effect of a wound cleansing solution on wound bed preparation and inflammation in chronic wounds: a single-blind RCT. J Wound Care 2016; 25(3): 160-8.
[55]
Tao Q, Ren J, Ji Z, Wang B, Zheng Y, Li J. Continuous topical irrigation for severely infected wound healing. J Surg Res 2015; 198(2): 535-40.
[56]
Min Y, Hatice H, Alpdogan K, et al. A pilot study evaluating non‐contact low‐frequency ultrasound and underlying molecular mechanism on diabetic foot ulcers. Int Wound J 2014; 11(6): 586-93.
[57]
Edwards J, Stapley S. Debridement of diabetic foot ulcers. Cochrane Database Syst Rev 2010; 1 CD003556
[59]
Kuo Y-S, Chien H-F, Lu W. Plectranthus amboinicus and Centella asiatica cream for the treatment of diabetic foot ulcers. Evid Based Complement Alternat Med 2012; 2012: 9.
[60]
Vaseenon T, Thitiboonsuwan S, Cheewawattanachai C, Pimchoo P, Phanphaisarn A. Off-loading total contact cast in combination with hydrogel and foam dressing for management of diabetic plantar ulcer of the foot. J Med Assoc Thai 2014; 97(12): 1319-24.
[61]
Chirwa Z, Bhengu T, Litiane K. The cost effectiveness of using calcium alginate silver matrix in the treatment of wounds. EWMA J 2010; 2(257): 299.
[62]
Dumville JC, Deshpande S, O’Meara S, Speak K. Foam dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev 2011; 9CD009111
[63]
Huang G, Sun T, Zhang L, et al. Combined application of alginate dressing and human granulocyte-macrophage colony stimulating factor promotes healing in refractory chronic skin ulcers. Exp Ther Med 2014; 7: 1772-6.
[64]
Vassallo I, Formosa C. Comparing calcium alginate dressings to vacuum-assisted closure: a clinical trial. Wounds 2015; 27(7): 180-90.
[65]
Dumville JC, O’Meara S, Deshpande S, Speak K. Alginate dressings for healing diabetic foot ulcers. Cochrane Database Syst Rev 2012; 2CD009110
[66]
O’Meara S, Martyn-St James M, Adderley UJ. Alginate dressings for venous leg ulcers. Cochrane Database Syst Rev 2015; 8 CD010182
[67]
Fleck CA, Simman R. Modern collagen wound dressings: function and purpose. J Am Coll Clin Wound Spec 2010; 2(3): 50-4.
[68]
Andrews K, Houdek M, Kiemele L. Wound management of chronic diabetic foot ulcers: from the basics to regenerative medicine. Prosthet Orthot Int 2015; 39(1): 29-39.
[69]
Mir G. Diabetic foot ulcer healing with a silver dressing combined with soft silicone technology. Wounds Int 2013; 4(3): 15-8.
[70]
Tsang K-K, Kwong EW-Y, To TS-S, Chung JW-Y, Wong TK-S. A pilot randomized, controlled study of nanocrystalline silver, manuka honey, and conventional dressing in healing diabetic foot ulcer. Evid.-Based Complementary Altern Med 2017; pp. 1-15.
[71]
Matsumoto Y, Kuroyanagi Y. Development of a wound dressing composed of hyaluronic acid sponge containing arginine and epidermal growth factor. J Biomater Sci Polym Ed 2010; 21(6-7): 715-26.
[72]
Moore AL, Marshall CD, Longaker MT. Minimizing skin scarring through biomaterial design. J Funct Biomater 2017; 8(1): 3.
[73]
Lee M, Han S, Choi W, Chung K, Lee J. Hyaluronic acid dressing (Healoderm) in the treatment of diabetic foot ulcer: A prospective, randomized, placebo-controlled, single-center study. Wound Rep Reg 2016; 24: 581-8.
[74]
Kavitha KV, Tiwari S, Purandare VB, Khedkar S, Bhosale SS, Unnikrishnan AG. Choice of wound care in diabetic foot ulcer: A practical approach. World J Diabetes 2014; 5(4): 546-56.
[75]
Mohammedi K, Potier L, François M, et al. The evaluation of off-loading using a new removable oRTHOsis in DIABetic foot (ORTHODIAB) randomized controlled trial: study design and rational. J Foot Ankle Res 2016; 9(1): 34.
[76]
Armstrong DG, Nguyen HC, Lavery LA, van Schie CHM, Boulton AJM, Harkless LB. Off-Loading the diabetic foot wound. A randomized clinical trial. Diabetes Care 2001; 24(6): 1019-22.
[77]
Scollan-Koliopoulos M. Theory-guided intervention for preventing diabetes-related amputations in African Americans. J Vasc Nurs 2004; 22(4): 126-33.
[78]
McInnes A, Jeffcoate W, Vileikyte L, et al. Foot care education in patients with diabetes at low risk of complications: a consensus statement. Diabet Med 2011; 28(2): 162-7.
[79]
Muhammad-Lutfi A, Zaraihah M, Anuar-Ramdhan I. Knowledge and practice of diabetic foot care in an in-patient setting at a tertiary medical center. Malays Orthop J 2014; 8(3): 22-6.
[80]
Nemcová J, Hlinková E. The efficacy of diabetic foot care education. J Clin Nurs 2014; 23(5-6): 877-82.
[81]
Ren M, Yang C, Lin DZ, Xiao HS, Mai LF, Guo YC, et al. Effect of intensive nursing education on the prevention of diabetic foot ulceration among patients with high-risk diabetic foot: a follow-up analysis. Diabetes Technol Ther 2014; 16(9): 576-81.
[82]
Holmes C, Wrobel JS, MacEachern MP, Boles BR. Collagen-based wound dressings for the treatment of diabetes-related foot ulcers: a systematic review. Diabetes Metab Syndr Obes 2013; 6: 17-29.
[83]
Mat Saad AZ, Khoo TL, Halim AS. Wound bed preparation for chronic diabetic foot ulcers. ISRN Endocrinol 2013; 2013608313
[84]
Mulder G, Tenenhaus M, D’Souza G. Reduction of diabetic foot ulcer healing times through use of advanced treatment modalities. Int J Low Extrem Wounds 2014; 13(4): 335-46.
[85]
Vyas KS, Vasconez HC. Wound healing: biologics, skin substitutes, biomembranes and scaffolds. Health Care 2014; 2(3): 356-400.
[86]
You H, Han S, Lee J, Chang H. Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes--a pilot study. Wound Repair Regen 2012; 20(4): 491-9.
[87]
Ma C, Hernandez M, Kirkpatrick V, Liang L, Nouvong A, Gordon I. Topical platelet-derived growth factor vs placebo therapy of diabetic foot ulcers offloaded with windowed casts: a randomized, controlled trial. Wounds 2015; 27(4): 83-91.
[88]
Suresh DH, Suryanarayan S, Sarvajnamurthy S, Puvvadi S. Treatment of a non-healing diabetic foot ulcer with platelet-rich plasma. J Cutan Aesthet Surg 2014; 7(4): 229-31.
[89]
Liu S, He C-Z, Cai Y-T, et al. Evaluation of negative-pressure wound therapy for patients with diabetic foot ulcers: systematic review and meta-analysis. Ther Clin Risk Manag 2017; 13: 533-44.
[90]
Nain PS, Uppal SK, Garg R, Bajaj K, Garg S. role of negative pressure wound therapy in healing of diabetic foot ulcers. J Surg Tech Case Rep 2011; 3(1): 17-22.
[91]
Kwan R, Wong W, Yip S, Chan K, Zheng Y, Cheing G. Pulsed electromagnetic field therapy promotes healing and microcirculation of chronic diabetic foot ulcers: a pilot study. Adv Skin Wound Care 2015; 28(5): 212-9.
[92]
Löndahl M. Hyperbaric oxygen therapy as treatment of diabetic foot ulcers. Diabetes Metab Res Rev 2012; 28: 78-84.
[93]
Yu J, Lu S, McLaren A-M, Perry JA, Cross KM. Topical oxygen therapy results in complete wound healing in diabetic foot ulcers. Wound Repair Regen 2016; 24(6): 1066-72.
[94]
Wainstein J, Feldbrin Z, Boaz M, Harman-Boehm I. Efficacy of ozone-oxygen therapy for the treatment of diabetic foot ulcers. Diabetes Technol Ther 2011; 13(12): 1255-60.
[95]
Dehghan M, Dehghan D, Sheikhrabori A, Sadeghi M, Jalalian M. Quality improvement in clinical documentation: does clinical governance work? J Multidiscip Healthc 2013; 6: 441-50.
[96]
Christman AL, Selvin E, Margolis DJ, Lazarus GS, Garza LA. Hemoglobin A1c is a predictor of healing rate in diabetic wounds. J Invest Dermatol 2011; 131(10): 2121-7.
[97]
Miyajima S, Shirai A, Yamamoto S, Okada N, Matsushita T. Risk factors for major limb amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract 2006; 71: 272-9.
[98]
Viswanathan V, Kesavan R, Kavitha KV, Kumpatla S. A pilot study on the effects of a polyherbal formulation cream on diabetic foot ulcers. Indian J Med Res 2011; 134(2): 168-73.
[99]
Nasiri M, Fayazi S, Jahani S, Yazdanpanah L, Haghighizadeh MH. The effect of topical olive oil on the healing of foot ulcer in patients with type 2 diabetes: a double-blind randomized clinical trial study in Iran. J Diabetes Metab Disord 2015; 14: 38.
[100]
Hunt SD, Elg F. Clinical effectiveness of hemoglobin spray (Granulox(®)) as adjunctive therapy in the treatment of chronic diabetic foot ulcers. Diabet Foot Ankle 2016; 7: 33101.
[101]
Ahmed M, Reffat SA, Hassan A, Eskander F. Platelet-rich plasma for the treatment of clean diabetic foot ulcers. Ann Vasc Surg 2017; 38(Suppl. C): 206-11.
[102]
Ikura K, Hanai K, Shinjyo T, Uchigata Y. HDL cholesterol as a predictor for the incidence of lower extremity amputation and wound-related death in patients with diabetic foot ulcers. Atherosclerosis 2015; 239(2): 465-9.
[103]
Massara M, Caridi GD, Serra R, et al. The role of procalcitonin as a marker of diabetic foot ulcer infection. Int Wound J 2017; 14(1): 31-4.
[104]
Park JH, Suh DH, Kim HJ, Lee YI, Kwak IH, Choi GW. Role of procalcitonin in infected diabetic foot ulcer. Diabetes Res Clin Pract 2017; 128(Suppl. C): 51-7.
[105]
Umapathy D, Dornadula S, Rajagopalan A, et al. Potential of circulatory procalcitonin as a biomarker reflecting inflammation among South Indian diabetic foot ulcers. J Vasc Surg 2018; 67(4): 1283-91.
[106]
Reiner MM, Khoury WE, Canales MB, et al. Procalcitonin as a biomarker for predicting amputation level in lower extremity infections. J Foot Ankle Surg 2017; 56(3): 484-91.
[107]
McArdle C, Lagan K, Spence S, McDowell D. Diabetic foot ulcer wound fluid: the effects of pH on DFU bacteria and infection. J Foot Ankle Res 2014; 8(Suppl. 1): A8.
[108]
Gethin G, Cowman S, Conroy R. The impact of Manuka honey dressings on the surface pH of chronic wounds. Int Wound J 2008; 5(2): 185-94.
Related Journals
Anti-Cancer Agents in Medicinal Chemistry
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Current Bioactive Compounds
Current Cancer Drug Targets
Combinatorial Chemistry & High Throughput Screening
Current Cancer Therapy Reviews
Current Drug Safety
Current Drug Targets
Current Drug Therapy
Current Drug Metabolism
Related Books
Frontiers in Clinical Drug Research-Dementia
COVID-19: Causes, Transmission, Diagnosis, and Treatment
Skeletal Muscle Health in Metabolic Diseases
Anthocyanins: Pharmacology and Nutraceutical Importance
The Roles and Responsibilities of Clinical Pharmacists in Hospital Settings
Common Lip Diseases: A Clinical Guide
Interventional Pain Surgery
Endoscopy and Fetoscopy Techniques for the Brain and Neuroaxis
Bioactive Compounds from Medicinal Plants for Cancer Therapy and Chemoprevention
Frontiers in Stem Cell and Regenerative Medicine Research
Article Metrics
83
23
1
1